Loading company details...
Beta
Latest Form 4 (Aug 25, 2026): William Norris Jennings (Director): Sale of 40,000 shares, $118.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 25, 2026 | William Norris Jennings | Sale | 40,000 | $118.4K |
| Jun 30, 2026 | K. Ranga Krishnan | Exercise/Conversion | 13,930 | n/a |
| Jun 1, 2026 | David Rice V., EVP-Clinical Operations & CMO | Grant/Award | 30,000 | n/a |
| Apr 22, 2026 | K. Ranga Krishnan | Exercise/Conversion | 46,950 | n/a |
| Mar 3, 2026 | Kevin A. Stockton, EVP, Operations & Development | Exercise/Conversion | 50,000 | n/a |
| Mar 3, 2026 | Phillip A. Posey, SVP & CAO | Grant/Award | 25,000 | n/a |
| Mar 3, 2026 | Justin D. Pitt, Pres,Chief Legal&Admin Officer | Exercise/Conversion | 30,000 | n/a |
| Mar 3, 2026 | Jason K. Johnson, EVP & CFO | Exercise/Conversion | 30,000 | n/a |
| Mar 3, 2026 | Kevin J. Hammons, CEO | Exercise/Conversion | 156,240 | n/a |
| Mar 3, 2026 | Hubert James Williams | Exercise/Conversion | 9,756 | n/a |